Sell4

CDT Equity Inc.

Total Value

$598

Filing Date

Oct 27, 2026

1 transaction

Trade Summary

On Jul 30, 2026 through Aug 28, 2026, Regan Andrew, Chief Executive Officer, Director, 10% Owner, reported $598 of CDT Equity Inc. (CDT) across 1 transaction. The filing covers Common Stock and reflects balanced net activity of $0. Reported prices ranged from $0.00. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.

Insider Information

Name: Regan Andrew
Role: Chief Executive Officer, Director, 10% Owner
Location: NAPLES, FL

Filing Details

Filing Date: Oct 27, 2026
Transaction Date: Jul 30, 2026
Accession Number: 0001753926-26-002009
Form Type: 4

Non-Derivative Transactions

Date	Security	Shares	Price	Type	Value
Aug 28, 2026	Common Stock	543,683	—	Other	—
Aug 28, 2026	Common Stock	29	—	Sale	—

Derivative Transactions

Date	Security	Shares	Exercise Price	Type	Value
Jul 30, 2026	CDT derivative	5,436,830	$0.00	Other	$544
Aug 28, 2026	CDT derivative	543,683	$0.00	Exercise	$54

Want live alerts when Regan Andrew trades again?

Download Insider Trades to track CDT, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.

iOS App Android App

Footnotes

(F1)This Form 4 Amendment (the "Amendment") is being filed to amend the Form 4 filed by Dr. Andrew Regan on September 2, 2026 (the "Original Form 4"), to (i) reflect the 1-for-10 reverse stock split of the outstanding shares of common stock, par value $0.0001 per share (the "Common Stock"), of CDT Equity Inc. (the "Issuer") effected on July 20, 2026, (ii) to add Corvus Capital Limited ("Corvus") as a filer due to their status as a 10% owner at the time of the filing of the Original Form 4, and (iii) update certain information regarding Manoira Corporation ("Manoira").
(F2)On July 30, 2026, Corvus entered into that certain securities purchase agreement (the "Agreement") with the Issuer and certain other investors of Sarborg Limited, a Cayman Islands Company ("Sarborg"), named therein, pursuant to which, on July 30, 2026, Corvus sold to the Issuer an aggregate of 120 shares of Sarborg (such shares the "Sarborg Shares") and the Issuer issued to Corvus as consideration for the Sarborg Shares pre-funded warrants (the "Pre-Funded Warrants") to purchase up to an aggregate of 543,683 shares of Common Stock, at an exercise price of $0.0001 per share.
(F3)The Pre-Funded Warrants include a "cashless" exercise provision, wherein the holder of the Pre-Funded Warrant is entitled to receive a number of shares of Common Stock generally equal to the quotient obtained by dividing the market price minus the exercise price divided by the market price (as further described in the Pre-Funded Warrant). The Pre-Funded Warrants became exercisable on August 28, 2026, following the receipt of stockholder approval for the issuance of the underlying Common Stock, and, on such date, Corvus exercised all of its Pre-Funded Warrants via cashless exercise and received 543,683 shares of Common Stock.
(F4)These shares of Common Stock and Pre-Funded Warrants are owned of record by Corvus.
(F5)Corvus is the owner of 87.0% of the equity interests of Manoira and, therefore, may also be deemed to beneficially own the shares of Common Stock held of record by Manoira. Dr. Andrew Regan is the Chief Executive Officer and sole shareholder of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock and Pre-Funded Warrants held of record by Manoira and Corvus. Each of Corvus and Dr. Regan disclaims any such beneficial ownership, except to the extent of its or his pecuniary interest therein.
(F6)These shares of Common Stock are owned of record by Manoira.
(F7)Corvus exercised the Pre-Funded Warrants on a cashless basis, which resulted in the Issuer withholding 290 shares of Common Stock issuable upon the exercise of the Pre-Funded Warrants to pay the exercise price.
(F8)The Pre-Funded Warrants have been exercised in full.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Regan Andrew

(Last)

(First)

(Middle)

4851 TAMIAMI TRAIL NORTH, SUITE 200

(Street)

NAPLES

34103

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
CDT Equity Inc. [ CDT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
07/30/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)
09/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	08/28/2026		J		543,683⁽¹⁾⁽²⁾⁽³⁾	A	⁽¹⁾⁽²⁾⁽³⁾	569,322	I	By Corvus Capital Ltd⁽⁴⁾⁽⁵⁾
Common Stock	08/28/2026		S⁽²⁾⁽³⁾⁽⁷⁾		29⁽¹⁾⁽²⁾⁽³⁾⁽⁷⁾	D	⁽¹⁾⁽²⁾⁽³⁾	569,322	I	By Corvus Capital Ltd.⁽⁴⁾⁽⁵⁾
Common Stock								560	D
Common Stock								77	I	By Manoira Corporation⁽⁵⁾⁽⁶⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Pre-Funded Warrants	$0.0001	07/30/2026		J⁽²⁾⁽³⁾		5,436,830⁽¹⁾⁽²⁾⁽³⁾⁽⁴⁾		⁽²⁾⁽³⁾	⁽⁸⁾	Common Stock	543,683⁽¹⁾⁽²⁾⁽³⁾⁽⁴⁾	$0.0001	543,683⁽¹⁾⁽²⁾⁽³⁾⁽⁴⁾	I	By Corvus Capital Ltd.⁽⁵⁾
Pre-Funded Warrants	$0.0001	08/28/2026		X			543,683⁽¹⁾⁽²⁾⁽³⁾⁽⁴⁾	08/28/2026	⁽⁸⁾	Common Stock	543,683⁽¹⁾⁽²⁾⁽³⁾⁽⁴⁾	$0.0001	0⁽²⁾⁽³⁾⁽⁴⁾	I	By Corvus Capital Ltd.⁽⁵⁾

1. Name and Address of Reporting Person^*

Regan Andrew

(Last)

(First)

(Middle)

4851 TAMIAMI TRAIL NORTH, SUITE 200

(Street)

NAPLES

34103

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

1. Name and Address of Reporting Person^*

Corvus Capital Ltd.

(Last)

(First)

(Middle)

FLOOR 2, WILLOW HOUSE, CRICKET SQUARE

P.O. BOX 709

(Street)

GRAND CAYMAN

KY1-1107

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

Explanation of Responses:

1. This Form 4 Amendment (the "Amendment") is being filed to amend the Form 4 filed by Dr. Andrew Regan on September 2, 2026 (the "Original Form 4"), to (i) reflect the 1-for-10 reverse stock split of the outstanding shares of common stock, par value $0.0001 per share (the "Common Stock"), of CDT Equity Inc. (the "Issuer") effected on July 20, 2026, (ii) to add Corvus Capital Limited ("Corvus") as a filer due to their status as a 10% owner at the time of the filing of the Original Form 4, and (iii) update certain information regarding Manoira Corporation ("Manoira").

2. On July 30, 2026, Corvus entered into that certain securities purchase agreement (the "Agreement") with the Issuer and certain other investors of Sarborg Limited, a Cayman Islands Company ("Sarborg"), named therein, pursuant to which, on July 30, 2026, Corvus sold to the Issuer an aggregate of 120 shares of Sarborg (such shares the "Sarborg Shares") and the Issuer issued to Corvus as consideration for the Sarborg Shares pre-funded warrants (the "Pre-Funded Warrants") to purchase up to an aggregate of 543,683 shares of Common Stock, at an exercise price of $0.0001 per share.

3. The Pre-Funded Warrants include a "cashless" exercise provision, wherein the holder of the Pre-Funded Warrant is entitled to receive a number of shares of Common Stock generally equal to the quotient obtained by dividing the market price minus the exercise price divided by the market price (as further described in the Pre-Funded Warrant). The Pre-Funded Warrants became exercisable on August 28, 2026, following the receipt of stockholder approval for the issuance of the underlying Common Stock, and, on such date, Corvus exercised all of its Pre-Funded Warrants via cashless exercise and received 543,683 shares of Common Stock.

4. These shares of Common Stock and Pre-Funded Warrants are owned of record by Corvus.

5. Corvus is the owner of 87.0% of the equity interests of Manoira and, therefore, may also be deemed to beneficially own the shares of Common Stock held of record by Manoira. Dr. Andrew Regan is the Chief Executive Officer and sole shareholder of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock and Pre-Funded Warrants held of record by Manoira and Corvus. Each of Corvus and Dr. Regan disclaims any such beneficial ownership, except to the extent of its or his pecuniary interest therein.

6. These shares of Common Stock are owned of record by Manoira.

7. Corvus exercised the Pre-Funded Warrants on a cashless basis, which resulted in the Issuer withholding 290 shares of Common Stock issuable upon the exercise of the Pre-Funded Warrants to pay the exercise price.

8. The Pre-Funded Warrants have been exercised in full.

	/s/ Andrew Regan	10/27/2026
	CORVUS CAPITAL LTD. /s/ Andrew Regan, Chief Executive Officer	10/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Form 4 as rendered by the SEC from accession 0001753926-26-002009.

CDT Equity Inc.

Trade Summary

Company Information

Insider Information

Filing Details

Non-Derivative Transactions

Derivative Transactions

Want live alerts when Regan Andrew trades again?

Footnotes

SEC Form 4

SEC Filing

SEC Form 4